IL

Isomorphic Labs

Application

AI drug discovery company using AlphaFold for pharmaceutical research.

Total funding$2.7B

Valuation—

Employees—

Founded2021

HeadquartersLondon, United Kingdom

StatusPrivate

Product

Selected offerings — the AI products recorded here, not the vendor's full catalogue.

• Drug Design Engine Platform

  Unified AI system, built on and beyond AlphaFold, that models drug candidates across small molecules and biologics for historically difficult targets. Used internally and through pharma co-development partnerships (e.g. Eli Lilly, Novartis) rather than sold directly.

Closest alternatives 2

CDChai DiscoveryPrivate · $3.8B1 of 1 capabilityShared product typeSourced competitorFind drug candidates fasterCompareRPRecursion PharmaceuticalsPublic · $1.9BBoth are AI-native drug-discovery platforms — Recursion OS against Isomorphic's Drug Design Engine — named as rivals in Recursion's own 10-K.1 of 1 capabilityShared product typeNamed in filingFind drug candidates fasterCompare

Similar products 7

How this list is ranked ↗

CCradlePrivate · $103M raisedDrug Design Engine and Cradle do comparable work on drug discovery; both also serve buyers who need to find drug candidates faster; similar scale (private).1 of 1 capabilityShared product typeCompareIMInsilico MedicinePublic · $4.3BDrug Design Engine and Pharma.AI do comparable work on drug discovery; both also serve buyers who need to find drug candidates faster; similar scale (public).1 of 1 capabilityShared product typeCompareOOwkinPrivate · $304.1M raisedDrug Design Engine and BiomarkerPlus do comparable work on drug discovery; similar scale (private); ships AI agent and data service rather than the same layer.1 of 1 capabilityDifferent layerCompareTATempus AIPublic · $12.4BDrug Design Engine and Tempus Lens do comparable work on drug discovery; similar scale (public); ships agent platform and application rather than the same layer.1 of 1 capabilityDifferent layerCompareGDGoogle DeepMindAcquiredDrug Design Engine and AlphaFold Server do comparable work on drug discovery; Google DeepMind is acquired, with no independent scale; ships application rather than the same layer.1 of 1 capabilityDifferent layerCompareNNVIDIAPublic · $5.1TDrug Design Engine and NVIDIA BioNeMo do comparable work on drug discovery; similar scale (public).1 of 1 capabilityShared product typeCompareHCHuawei CloudPrivateDrug Design Engine and EIHealth do comparable work on drug discovery; Huawei Cloud's scale not recorded.1 of 1 capabilityShared product typeCompare

Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.

Sources

Total funding

Press release · 28 Aug 2026

$600M external round (2025-03-31, isomorphiclabs.com/articles/isomorphic-labs-announces-600m-external-investment-round) + $2.1B Series B (2026-05-12, this url) = $2.7B, both from the company's own press releases. Neither release states a cumulative total; this is the sum of the two disclosed rounds.

Employees

Checked — none published

Checked 2026-08-27 and no citable figure found. Four sweeps were run and all came back empty for this company: (1) its own /about, /about-us, /company, /careers, /jobs and /team pages, pattern-matched for a self-published headcount; (2) stockanalysis.com's private-company page, which footnotes each figure to its source; (3) its Forbes company profile, which states a headcount and the month it is as of; (4) a targeted web search. Everything the search returned was a LinkedIn-scraping aggregator, and those disagree with each other by wide margins and cite nothing, so they are not used here. The field is null rather than carrying the round guess it held before.

Founded

Wikipedia · 27 Aug 2026

Wikipedia infobox "founded" field, read 2026-08-27.

Open Isomorphic Labs in the directory

Something wrong here? Send a correction — quote this company id: isomorphic-labs.